Skylight Health Group- 9.25% PRF PERPETUAL USD 25 - Ser A's EBIT is $-18M, below the Consumer Staples sector average of $21B.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2022
Trailing 12 months ending Jun 30, 2022
As of the most recent data (June 2022), SLHGP shows a EBIT of $-18M. That compares with $-14M in the prior-year period — down 27.6% year over year. That is below the Consumer Staples sector average of $21B. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SLHGP's EBIT is now $-18M (was $-14M) — a 27.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Skylight Health Group- 9.25% PRF PERPETUAL USD 25 - Ser A is outperforming or lagging.
The Consumer Staples sector average EBIT is about $21B. Skylight Health Group- 9.25% PRF PERPETUAL USD 25 - Ser A is at $-18M, which is lower that average. That is roughly 100.1% below the sector mean. Use the comparison chart on this page to see how SLHGP stacks up against individual peers as well.
Tracking SLHGP's ebit over time shows whether Skylight Health Group- 9.25% PRF PERPETUAL USD 25 - Ser A is scaling, shrinking, or reshaping that part of the business. The current reading is $-18M That compares with $-14M in the prior-year period — down 27.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has Skylight Health Group- 9.25% PRF PERPETUAL USD 25 - Ser A's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-18M) with ownership activity and broader fundamentals.